Status:
COMPLETED
CBT vs. ABM vs. for Social Anxiety
Lead Sponsor:
Hebrew University of Jerusalem
Collaborating Sponsors:
Israel Science Foundation
Conditions:
Social Phobia
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Adults with Social Anxiety Disorder will be pseudo randomly assigned to either an individual cognitive behavior therapy, attention bias modification treatment (allocation ratio - 1.5:1). Outcome meas...
Detailed Description
120 Adults with Social Anxiety Disorder will be pseudo randomly assigned to either an individual cognitive behavior therapy (CBT), attention bias modification treatment (ABM)). Outcome measures will ...
Eligibility Criteria
Inclusion
- Diagnosis of Generalized Social Anxiety Disorder, LSAS\>50
- If on medication, patients must be on a stable dose
- Hebrew language fluency
Exclusion
- Primary Axis I or Axis II disorder other than SAD
- suicidal ideation
- Substance dependence within the past three months or current substance abuse
- Mental retardation or another pervasive developmental disability
- Current or past schizophrenia or psychosis, current bipolar disorder, or organic brain syndrome
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT01909193
Start Date
January 1 2011
End Date
November 1 2014
Last Update
February 23 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Hebrew University of Jerusalem
Jerusalem, Israel